Vascular Closure Devices Market Growth Outlook Through 2024-2033 | Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips NV, Boston Scientific Corporation

Overview and Scope
A vascular closure device is a medical device that seals the entry point in an artery after a catheterization procedure. These devices are designed to accelerate the natural healing process and minimize the risk of bleeding, hematoma formation, or other complications at the access site.

Sizing and Forecast
The vascular closure devices market size has grown strongly in recent years. It will grow from $1.42 billion in 2023 to $1.53 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%.  The  growth in the historic period can be attributed to growth in minimally invasive procedures, aging population demographics, patient preference for shorter recovery times, increased catheterization lab procedures, focus on outpatient care..

The vascular closure devices market size is expected to see strong growth in the next few years. It will grow to $1.97 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%.  The growth in the forecast period can be attributed to rise in ambulatory surgery centers, shift toward same-day discharge, patient-centric approaches, healthcare cost containment initiatives, increasing incidence of cardiovascular diseases.. Major trends in the forecast period include adoption of percutaneous coronary intervention, global collaboration in medical research, remote patient monitoring, integration with imaging technologies, technological innovations in device design..

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/vascular-closure-devices-global-market-report

Segmentation & Regional Insights
The vascular closure devices market covered in this report is segmented –
1) By Type: Passive Approximators, Active Approximators, External Hemostatic Devices
2) By Access: Femoral Access, Radial Access
3) By End User: Acute Care Facilities, Hospitals, Clinics, Other End Users

North America was the largest region in the vascular closure devices market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13201&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the vascular closure devices market. Cardiovascular disease (CVD) refers to conditions that affect the structures or function of the heart or blood vessels, affecting blood flow to the heart. Vascular closure devices (VCDs) are a substitute for conventional mechanical compression to close the femoral artery and offer rapid sealing of the femoral artery access site, potentially resulting in quicker attainment of hemostasis and a reduced risk of bleeding or hemorrhage following placement. For instance, in June 2023, according to the Immigration and Checkpoints Authority, a Singapore-based law enforcement agency, the number of people who died from heart and hypertensive diseases in Singapore increased from 6,238 in 2021 to 6,884 in 2022. Therefore, the increasing prevalence of cardiovascular diseases is expected to propel the growth of the vascular closure devices market.

Key Industry Players
Major companies operating in the vascular closure devices market report are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips NV, Boston Scientific Corporation, Terumo Corporation, C.R. Bard Inc., Cook Medical Inc., W. L. Gore & Associates Inc., Maquet Getinge Group, Teleflex Inc., BTG International Inc., Biotronik GMBH & CO.KG, Merit Medical System Inc., Vygon SA, Cardiovascular Systems Inc., Sirtex Medical Limited, Endologix LLC, TZ Medical Inc., Cardiva Medical Inc., Essential Medical Inc., KOAG LLC, Morris Innovative Inc., Vasorum Ltd., Scion BioMedical Inc., Z-Media LLC, Advanced Vascular Dynamics, Transluminal Technologies Inc., Tricol Medical Inc.

The vascular closure devices market report table of contents includes:
1. Executive Summary
2. Vascular Closure Devices Market Characteristics
3. Vascular Closure Devices Market Trends And Strategies
4. Vascular Closure Devices Market – Macro Economic Scenario
5. Global Vascular Closure Devices Market Size and Growth
…………….
32. Global Vascular Closure Devices Market Competitive Benchmarking
33. Global Vascular Closure Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Vascular Closure Devices Market
35. Vascular Closure Devices Market Future Outlook and Potential Analysis
36. Appendix

Explore the trending research reports from TBRC:

https://topprnews.com/vascular-closure-devices-market-outlook/
https://topprnews.com/tourism-event-market-forecast/
https://topprnews.com/global-voice-and-speech-analytics-market-growth/
https://goodprnews.com/small-hydropower-market-growth/
https://goodprnews.com/tourism-event-market-forecast/
https://goodprnews.com/voice-and-speech-analytics-market-forecast/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model